Table 5.

Endocrine profile of the pituitary-gonadal axis in male patients before and after busulfan conditioning and beti-cel infusion

Before busulfan conditioning and beti-cel infusionAfter busulfan conditioning and beti-cel infusion
Patient 1Patient 2Patient 3Patient 6Patient 8Patient 1Patient 2Patient 3Patient 6Patient 8
LH, U/L (normal, 0.79-11.75) 1.4 7.86 n.a. 4.24 0.47 8.94 6.87 6.36 0.52 
FSH, U/L (normal, 1.08-12.85) 2.2 4.99 n.a. 12.8 0.81 n.a. 9.38 9.94 12.05 3.08 
Testosterone, ng/mL (normal, 2-7) n.a. n.a. n.a. 6.83 n.a. 4.4 3.44 5.54 0.98 
Inhibin B, ng/L (normal, >120) n.a. n.a. n.a. n.a. n.a. n.a. 20 487 10 122 
Before busulfan conditioning and beti-cel infusionAfter busulfan conditioning and beti-cel infusion
Patient 1Patient 2Patient 3Patient 6Patient 8Patient 1Patient 2Patient 3Patient 6Patient 8
LH, U/L (normal, 0.79-11.75) 1.4 7.86 n.a. 4.24 0.47 8.94 6.87 6.36 0.52 
FSH, U/L (normal, 1.08-12.85) 2.2 4.99 n.a. 12.8 0.81 n.a. 9.38 9.94 12.05 3.08 
Testosterone, ng/mL (normal, 2-7) n.a. n.a. n.a. 6.83 n.a. 4.4 3.44 5.54 0.98 
Inhibin B, ng/L (normal, >120) n.a. n.a. n.a. n.a. n.a. n.a. 20 487 10 122 
Close Modal

or Create an Account

Close Modal
Close Modal